PubRank

Feasibility of PainCare Yoga for Knee OA

Clinical Trial ID NCT04954586

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04954586

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 1994 3.70
2 Brain-derived neurotrophic factor. Growth Factors 2004 3.66
3 Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994 2.36
4 BDNF as a pain modulator. Prog Neurobiol 2008 1.73
5 BDNF in sensory neurons and chronic pain. Neurosci Res 2006 1.38
6 Unraveling the story of NGF-mediated sensitization of nociceptive sensory neurons: ON or OFF the Trks? Mol Interv 2007 1.26
7 Structural associations of symptomatic knee osteoarthritis. Arthritis Rheumatol 2014 1.02
8 Perception of pain after resistance exercise. Br J Sports Med 1998 1.01
9 Effects of exercise and physical activity on knee osteoarthritis. Curr Pain Headache Rep 2011 0.98
10 Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management. J Neurochem 2013 0.94
11 Exercise for osteoarthritis of the knee: a Cochrane systematic review. Br J Sports Med 2015 0.92
12 Requirement for nerve growth factor in the development of myelinated nociceptors in vivo. Nature 1991 0.91
13 Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opin Ther Targets 2014 0.86
14 Acute resistance exercise induces antinociception by activation of the endocannabinoid system in rats. Anesth Analg 2014 0.80
15 Effects of hata yoga on knee osteoarthritis. Int J Prev Med 2013 0.79
16 Involvement of BDNF in knee osteoarthritis: the relationship with inflammation and clinical parameters. Rheumatol Int 2014 0.78
17 Managing knee osteoarthritis with yoga or aerobic/strengthening exercise programs in older adults: a pilot randomized controlled trial. Rheumatol Int 2016 0.75
18 Current status of nerve growth factor antibodies for the treatment of osteoarthritis pain. Clin Exp Rheumatol 2017 0.75
Next 100